About this trial
The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is:
\- is there a benefit in functional muscle power output of the leg?
Participants will be randomized into either the intervention group or the control group and:
* receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) * receive Femoral Nerve Block (FNB) + IPACK in control group (group 2)
Researchers will compare the 2 groups to see if there are differences in :
* functional muscle power output of the leg? * muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?
Eligibility criteria
Qualifiers
age > 18yrs
primary TKA
BMI 35kg/m2 or less
able to give informed consent as documented by signature
Disqualifiers
age < 18 years
revision-TKA
BMI >35kg/m2
absent contact information
Trial design
Treatments tested in this trial
- SSNB + IPACK
- FNB + IPACK
Treatment groups
Locations
1Sponsors and collaborators
Luzerner Kantonsspital
Lead sponsor